Amanote Research
Register
Sign In
Php353 - Romanian Experience With Managed Entry Agreements for Drugs
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1247
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
P. Radu
I. Stoica
P. Udroiu
Publisher
Elsevier BV
Related search
Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
What Principles Should Govern the Use of Managed Entry Agreements?
International Journal of Technology Assessment in Health Care
Health Policy
Adoption of Managed Entry Agreements in Established and Emerging Markets
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php249 - Are Traditional Managed Entry Agreements Suitable for Potentially, Curative Gene/Cell Therapies?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Managed Entry Agreements (MEA): Analysis of the Current Situation in Middle East and North Africa
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy188 - Use of Managed Entry Agreements in Inflammatory Disorders Among Key Health Technology Assessment Agencies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Scientific Methodology and Practical Use of Managed Entry Agreements for Innovative Medicines in System of Health Technology Assessment in Ukraine
Farmatsevtychnyi zhurnal
Managed Trade: The US-Mexico Sugar Suspension Agreements
Canadian Journal of Economics
Economics
Econometrics
The Adolescent With Cancer's School Re-Entry Experience
